ラテラルフローアッセイの世界市場予測(~2023年)

【英語タイトル】Lateral Flow Assay Market by Application (Clinical Testing (Pregnancy, Infectious Disease (Mosquito , Influenza, STI, Hepatitis, TB), Cardiac Marker, Lipid Test) Veterinary, Food Safety) Product (Reader, Kits) Technique, End User - Global Forecast to 2023

MarketsandMarketsが出版した調査資料(MD-4158)・商品コード:MD-4158
・発行会社(調査会社):MarketsandMarkets
・発行日:2018年11月13日
・ページ数:289
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥627,150見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥738,150見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥904,650見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
ラテラルフローアッセイの世界市場は、2018年の60億米ドルから2023年には87億米ドルに達し、この期間中5.9%の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、感染症の高罹患率、急速に増加する高齢者人口、ラテラルフローアッセイ装置の在宅使用の増加、ポイントオブケア検査に対する需要の増加などが考えれられます。一方で、既存の診断方法からの変更に消極的なこと、医療機器に対する物品税、および厳格かつ時間のかかる規制方針により、市場の成長は抑制される可能性があります。当調査レポートでは、ラテラルフローアッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、用途(臨床検査、動物用検査、食品安全)分析、製品(リーダー、キット)分析、技術分析、エンドユーザー分析、ラテラルフローアッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

“The global lateral flow assay market projected to grow at a CAGR of 7.7%.”The global lateral flow assay market is projected to reach USD 8.7 billion by 2023 from USD 6.0 billion in 2018 growing at a CAGR of 7.7% from 2018 to 2023. Factor such as the high prevalence of infectious diseases across the globe, rapidly increasing geriatric population, increasing usage of home-based lateral flow assay devices, and growing demand for point-of-care testing are fueling the growth of the market. However, reluctance towards changing existing diagnostic practices, the implementation of excise duty on medical devices, and stringent & time-consuming regulatory policies are restricting market growth to a certain extent.

“The lateral flow readers segment is expected to register the highest CAGR during the forecast period.”
On the basis of product, the lateral flow assay market is segmented into kits & reagents and lateral flow readers. The lateral flow readers segment is expected to register the highest CAGR during the forecast period. The high growth in this segment is attributed to the growing awareness about digital/mobile readers, technological advancements, and higher accuracy offered by these readers.

“Shift from lab based technique to rapid testing is expected to drive the market for food safety & environmental testing during the forecast period.”
Based on application, the lateral flow assay market is segmented into clinical testing, veterinary diagnostics, food safety and environmental testing, and drug development & quality control testing. The food safety and environmental testing segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is driven by the shifting of the food & beverage industry from lab-based conventional microbiology techniques to rapid lateral flow assay tests.

“APAC is projected to witness the highest growth during the forecast period.”
North America held the largest share of the global lateral flow assay market in 2017. On the other hand, the Asia-Pacific region is expected to witness the highest CAGR during the forecast period, owing to the rapidly developing healthcare industry in China and India, growth in aging population, rising life expectancy, rising per capita income, increasing investments in the region by key market players, the expansion of private-sector hospitals & clinics to rural areas, the availability of low-cost labor for manufacturing, presence of a favorable regulatory environment, and growing demand for home and POC testing.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–45%, Tier 2–25% and Tier 3–30%
• By Designation – C-level–40%, Director Level–25%, Others–35%
• By Region – North America–36%, Europe–26%, Asia-Pacific–21%, Latin America–10%, Middle East & Africa–7%

The prominent players in the global lateral flow assay market are Abbott Laboratories (US), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (US), Siemens AG (Germany), Becton, Dickinson and Company (US), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), QIAGEN N.V. (The Netherlands), PerkinElmer, Inc. (US), Hologic, Inc. (US), Merck Millipore (US), Quidel Corporaton (US), Abcam plc. (US), DCN Diagnostics (US), Surmodics, Inc. (US), BioPorto Diagnostics A/S (Denmark), Chembio Diagnostic Systems, Inc. (US), Polysciences, Inc. (US), Innova Biosciences Ltd. (UK), Microcoat Biotechnologie GmbH (Germany), Senova GmbH (Germany), Scienion AG (Germany), and Orasure Diagnostics (US).
Research Coverage:
The report analyzes the various types of kits & reagents and their adoption pattern. It aims at estimating the market size and future growth potential of the global lateral flow assay market for different segments such as product, application, technique, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Key benefits of buying the report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global lateral flow assay market. The report analyzes the global lateral flow assay market by product, application, technique, end user, and region
• Product Development/Innovation: Detailed insights on upcoming trends and new product launches in the global lateral flow assay market
• Market Development: Comprehensive information on the lucrative emerging regions by product, application, technique, end user, and region
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global lateral flow assay market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global lateral flow assay market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.3 MARKET SCOPE 27
1.3.1 MARKETS COVERED 27
1.3.2 YEARS CONSIDERED FOR THE STUDY 28
1.4 CURRENCY 28
1.5 LIMITATIONS 28
1.6 STAKEHOLDERS 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
2.1.1 SECONDARY DATA 31
2.1.1.1 Key data from secondary sources 32
2.1.2 PRIMARY DATA 33
2.1.2.1 Key data from primary sources 34
2.1.2.2 Key industry insights 35
2.2 MARKET SIZE ESTIMATION 37
2.2.1 BOTTOM-UP APPROACH 37
2.2.2 TOP-DOWN APPROACH 38
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 39
2.4 MARKET SHARE ESTIMATION 40
2.5 ASSUMPTIONS FOR THE STUDY 40
3 EXECUTIVE SUMMARY 41
4 PREMIUM INSIGHTS 45
4.1 LATERAL FLOW ASSAYS: MARKET OVERVIEW 45
4.2 LATERAL FLOW ASSAYS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES/REGION 46
4.3 LATERAL FLOW ASSAYS MARKET: MAJOR COUNTRIES 47
4.4 GEOGRAPHIC MIX: LATERAL FLOW ASSAYS MARKET 48
4.5 LATERAL FLOW ASSAYS MARKET IN ASIA PACIFIC, BY APPLICATION AND COUNTRIES 49

5 MARKET OVERVIEW 50
5.1 INTRODUCTION 50
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 50
5.2.1 MARKET DRIVERS 51
5.2.1.1 High prevalence of infectious diseases across the globe 51
5.2.1.2 Rapidly increasing geriatric population 53
5.2.1.3 Growing usage of home-based lateral flow assay devices 54
5.2.1.4 Growing demand for point-of-care testing 54
5.2.2 MARKET RESTRAINTS 55
5.2.2.1 Reluctance towards changing existing diagnostic practices 55
5.2.2.2 Implementation of excise duty on medical devices in the US 55
5.2.3 MARKET OPPORTUNITIES 55
5.2.3.1 Evolving applications of lateral flow assays 55
5.2.3.2 Rising demand for lateral flow assays in the food & beverage industry 56
5.2.4 CHALLENGES 57
5.2.4.1 Limited reimbursements for lateral flow assay products 57
6 INDUSTRY INSIGHTS 58
6.1 INTRODUCTION 58
6.2 INDUSTRY TRENDS 58
6.2.1 INTEGRATION OF MICROFLUIDIC TECHNOLOGY IN LATERAL FLOW ASSAYS 58
6.2.2 DEMAND FOR QUANTITATIVE RESULTS 59
6.2.3 RISING DEMAND FOR MULTIPLEXED LATERAL FLOW BIOSENSORS 59
6.3 VALUE CHAIN ANALYSIS 60
6.4 SUPPLY CHAIN ANALYSIS 61
6.5 REGULATORY ANALYSIS 62
6.5.1 NORTH AMERICA 63
6.5.2 EUROPE 64
6.5.3 ASIA 64
6.5.3.1 India 64
6.5.3.2 China 64
6.5.3.3 Japan 64
6.6 PARENT MARKETS ANALYSIS 65

7 LATERAL FLOW ASSAYS MARKET, BY PRODUCT 70
7.1 INTRODUCTION 71
7.2 KITS & REAGENTS 72
7.2.1 INCREASING DEMAND FOR POC TESTING IS DRIVING THE DEMAND FOR KITS AND REAGENTS IN THE LATERAL FLOW ASSAYS MARKET 72
7.3 LATERAL FLOW READERS 73
7.3.1 DIGITAL/MOBILE READERS 74
7.3.1.1 Growing awareness, technological advancements, and high accuracy are major factors driving the growth of the digital/mobile readers market. 74
7.3.2 BENCHTOP READERS 76
7.3.2.1 Lower diagnosis cost per patient is driving the benchtop readers market 76
8 LATERAL FLOW ASSAYS MARKET, BY APPLICATION 77
8.1 INTRODUCTION 78
8.2 CLINICAL TESTING 79
8.2.1 INFECTIOUS DISEASE TESTING 80
8.2.1.1 Mosquito-borne disease testing 82
8.2.1.1.1 Increasing incidence of dengue driving the growth of the lateral flow assay market for mosquito-borne testing 82
8.2.1.2 Influenza testing 84
8.2.1.2.1 Growing prevalence of influenza is expected to drive the influenza testing market. 84
8.2.1.3 Sexually transmitted infection testing 85
8.2.1.3.1 HIV Testing 86
8.2.1.3.1.1 Growing awareness about HIV POC testing are the major factors driving market growth. 86
8.2.1.3.2 HPV testing 88
8.2.1.3.2.1 Rising adoption of HPV testing is expected to drive the market during forecast period 88
8.2.1.3.3 Chlamydia testing 89
8.2.1.3.3.1 Consistantly growing incidence of chlamydia and rising awareness among patients is driving this market 89
8.2.1.3.4 Gonorrhea testing 91
8.2.1.3.4.1 The rising incidence of gonorrhea globally is expected to drive the lateral flow assays market during the forecast period. 91
8.2.1.3.5 Syphilis testing 92
8.2.1.3.5.1 The growing adoption of novel technologies supporting the growth of the lateral flow assays market for syphilis testing 92
8.2.1.3.6 Other sexually transmitted infection testing 94
8.2.1.4 Hepatitis 95
8.2.1.4.1 Nucleic acid hybridization-based lateral flow assays hold great potential in hepatitis testing market 95
8.2.1.5 Tuberculosis 96
8.2.1.5.1 Rising prevalence of the disease and a growing focus on early diagnosis and treatment of tuberculosis is expected to drive this market 96
8.2.1.6 Other infectious disease tests 97
8.2.2 CARDIAC MARKER TESTING 98
8.2.2.1 Troponin I and T testing 99
8.2.2.1.1 Introduction of high-sensitivity troponin assays is expected to drive this market during the forecast period 99
8.2.2.2 CK-MB testing 101
8.2.2.2.1 Growing application of lateral flow tests in acute myocardial injuries is expected to drive this market 101
8.2.2.3 BNP and NT-proBNP testing 102
8.2.2.3.1 Increasing demand for cardiac biomarker tests to detect heart stress and damage to drive the growth in this market 102
8.2.2.4 Myoglobin testing 103
8.2.2.4.1 Availability of new high-sensitivity cardiac troponin assays to restrict the growth of the routine myoglobin testing market 103
8.2.2.5 D-Dimer testing 104
8.2.2.5.1 The rising incidence of cardiovascular diseases globally is expected to drive the market for D-dimer tests 104
8.2.2.6 Other cardiac marker tests 105
8.2.3 PREGNANCY & FERTILITY TESTING 106
8.2.3.1 Pregnancy testing 108
8.2.3.1.1 Pregnancy testing is among well-established application areas for lateral flow assays, registering slower growth during the forecast period 108
8.2.3.2 Fertility testing 109
8.2.3.2.1 Rising infertility rates across the globe driving the demand for POC fertility testing kits. 109
8.2.4 CHOLESTEROL TESTING/LIPID PROFILE 110
8.2.4.1 The growing prevalence of obesity and CVD is the key factor driving market growth 110
8.2.5 DRUGS OF ABUSE TESTING 111
8.2.5.1 Technological advancements, rising public awareness, and growing focus on workplace drug testing is driving the drugs of abuse testing market 111
8.2.6 OTHER CLINICAL TESTS MARKET 112
8.3 VETERINARY DIAGNOSTICS 113
8.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) IS DRIVING THE DEMAND FOR LATERAL FLOW TESTS 113
8.4 FOOD SAFETY & ENVIRONMENT TESTING 115
8.4.1 HIGH SENSITIVITY AND EASE OF USE DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 115

8.5 DRUG DEVELOPMENT & QUALITY TESTING 116
8.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE IS DRIVING THE GROWTH OF THIS MARKET 116
9 LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE 118
9.1 INTRODUCTION 119
9.2 SANDWICH ASSAYS 120
9.2.1 WIDE APPLICATIONS OF SANDWICH ASSAYS IN CLINICAL TESTING CONTRIBUTING TO THE LARGEST SHARE OF THIS SEGMENT 120
9.3 COMPETITIVE ASSAYS 121
9.3.1 HORMONE TESTING, DRUG TESTING, AND DRUGS OF ABUSE TESTING ARE PRIMARY APPLICATION AREAS OF COMPETITIVE ASSAYS 121
9.4 MULTIPLEX DETECTION ASSAYS 122
9.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE THE GROWTH OF THIS MARKET 122
10 LATERAL FLOW ASSAYS MARKET, BY END USER 123
10.1 INTRODUCTION 124
10.2 HOSPITALS & CLINICS 125
10.2.1 INCREASING USE OF POC TESTS AND FASTER DIAGNOSIS DRIVING ADOPTION OF LATERAL FLOW ASSAYS AMONG HOSPITALS & CLINICS 125
10.3 DIAGNOSTIC LABORATORIES 126
10.3.1 LABORATORY TESTING IS LARGELY PREFERRED OVER PROFESSIONAL SETTINGS FOR URINE AND BLOOD TESTING 126
10.4 HOME CARE 127
10.4.1 GROWING ACCEPTANCE OF HOME AND REMOTE MONITORING DRIVING THE GROWTH OF THE LATERAL FLOW ASSAYS MARKET FOR HOME CARE 127
10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 129
10.5.1 INCREASING FOCUS ON PRODUCT SAFETY EXPECTED TO DRIVE THE GROWTH OF THE LATERAL FLOW ASSAYS MARKET AMONG PHARMACEUTICAL AND BIOTECH COMPANIES 129
10.6 OTHERS END USERS 130
11 LATERAL FLOW ASSAYS MARKET, BY REGION 131
11.1 INTRODUCTION 132
11.2 NORTH AMERICA 134
11.2.1 US 140
11.2.1.1 The US accounts for the largest share of the global lateral flow assays market 140
11.2.2 CANADA 145
11.2.2.1 The availability of research funding and implementation of favorable government initiatives is driving the market in Canada 145
11.3 EUROPE 150
11.3.1 GERMANY 156
11.3.1.1 Along with home care, growing number of the POC diagnostics centers driving the demand for lateral flow assays in Germany 156
11.3.2 FRANCE 161
11.3.2.1 Prevalence of age-related chronic diseases and infectious diseases is expected to drive the market growth in France 161
11.3.3 UK 166
11.3.3.1 Increasing incidence of chronic diseases and rising prevalence of obesity propelling the market growth in the UK 166
11.3.4 ITALY 171
11.3.4.1 Growing initiatives towards decentralization of medical services in Italy is contributing to the market growth in the country 171
11.3.5 SPAIN 176
11.3.5.1 Increasing focus of international organizations and domestic players toward the development of POC products in the country 176
11.3.6 REST OF EUROPE 181
11.4 ASIA PACIFIC 186
11.4.1 CHINA 192
11.4.1.1 Along with clinical diagnostics, the growing adoption of lateral flow assays in veterinary diagnostics and drug development expected to drive the market growth in China 192
11.4.2 JAPAN 197
11.4.2.1 Increasing prevalence of age-related illnesses, attributed to the growth in country’s geriatric population driving the growth of the lateral flow assays market in Japan 197
11.4.3 INDIA 202
11.4.3.1 Increasing prevalence of chronic disorders, growing healthcare concerns, and rising income levels is expected to propel the growth of this market 202
11.4.4 REST OF ASIA PACIFIC 207
11.5 LATIN AMERICA 212
11.5.1 INCREASING INCIDENCE OF CHRONIC DISEASES DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS IN LATIN AMERICA 212
11.6 MIDDLE EAST & AFRICA 217
11.6.1 SIGNIFICANT SUPPORT FROM THE GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANSION OF HEALTHCARE SERVICES IS DRIVING ADOPTION OF LATERAL FLOW ASSAYS IN THE AFRICAN REGION 217

12 COMPETITIVE LANDSCAPE 223
12.1 INTRODUCTION 223
12.2 PRODUCT PORTFOLIO ANALYSIS 224
12.3 GEOGRAPHICAL ASSESSMENT OF MAJOR PLAYERS IN THE LATERAL FLOW ASSAYS MARKET 225
12.4 MARKET SHARE ANALYSIS (2017) 226
12.5 COMPETITIVE SITUATIONS AND TRENDS 228
12.5.1 PRODUCT LAUNCHES 228
12.5.2 ACQUISITIONS 228
12.5.3 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 229
12.5.4 EXPANSIONS 229
12.6 COMPETITIVE ASSESSMENT OF R&D EXPENDITURE 230
13 COMPANY PROFILES 231
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
13.1 ABBOTT LABORATORIES 231
13.2 F. HOFFMANN-LA ROCHE AG 236
13.3 DANAHER CORPORATION 240
13.4 SIEMENS AG 244
13.5 BECTON, DICKINSON AND COMPANY 248
13.6 BIOMÉRIEUX SA 252
13.7 BIO-RAD LABORATORIES, INC. 255
13.8 THERMO FISHER SCIENTIFIC INC. 258
13.9 QIAGEN N.V. 263
13.10 PERKINELMER INC. 266
13.11 HOLOGIC INC. 270
13.12 QUIDEL CORPORATION 273
13.13 MERCK KGAA 276
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
14 APPENDIX 279
14.1 INSIGHTS OF INDUSTRY EXPERTS 279
14.2 DISCUSSION GUIDE 280
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 285
14.4 AVAILABLE CUSTOMIZATIONS 287
14.5 RELATED REPORTS 287
14.6 AUTHOR DETAILS 288

LIST OF TABLES

TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 28
TABLE 2 PREVALENCE OF HIV WORLDWIDE (2016-2017) 52
TABLE 3 REGULATORY STANDARD/APPROVAL REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 62
TABLE 4 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 71
TABLE 5 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 72
TABLE 6 LATERAL FLOW READERS IN THE MARKET 73
TABLE 7 LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 73
TABLE 8 LATERAL FLOW READERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 74
TABLE 9 DIGITAL/MOBILE READERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 75
TABLE 10 BENCHTOP READERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 76
TABLE 11 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 78
TABLE 12 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE,
2016–2023 (USD MILLION) 79
TABLE 13 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY,
2016–2023 (USD MILLION) 80
TABLE 14 INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 81
TABLE 15 INFECTIOUS DISEASE TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 81
TABLE 16 MAJOR PRODUCTS: DENGUE TESTING 83
TABLE 17 MOSQUITO-BORNE DISEASE TESTING MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 83
TABLE 18 INFLUENZA TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 84
TABLE 19 SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 85
TABLE 20 SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 86
TABLE 21 HIV TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 88
TABLE 22 HPV TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 89
TABLE 23 INCIDENCE OF CHLAMYDIA, BY COUNTRY, 2010–2016 (‘000) 90
TABLE 24 CHLAMYDIA TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 90
TABLE 25 GONORRHEA TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 91
TABLE 26 INCIDENCE OF SYPHILIS, BY COUNTRY, 2010–2016 92
TABLE 27 SYPHILIS TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 93
TABLE 28 OTHER SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 94
TABLE 29 HEPATITIS TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 95
TABLE 30 TUBERCULOSIS TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 96
TABLE 31 OTHER INFECTIOUS DISEASE TESTS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 97
TABLE 32 CARDIAC MARKER TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 98
TABLE 33 CARDIAC MARKER TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 99
TABLE 34 TROPONIN I AND T TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 100
TABLE 35 CK-MB TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 101
TABLE 36 BNP & NT-PROBNP TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 102
TABLE 37 MYOGLOBIN TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 103
TABLE 38 D-DIMER TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 104
TABLE 39 OTHER CARDIAC MARKER TESTS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 105
TABLE 40 PREGNANCY & FERTILITY TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 106
TABLE 41 PREGNANCY & FERTILITY TESTING MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 107
TABLE 42 PREGNANCY TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 108
TABLE 43 FERTILITY TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 109
TABLE 44 CHOLESTEROL TESTING/LIPID PROFILE MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 110
TABLE 45 DRUGS OF ABUSE TESTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 111
TABLE 46 OTHER CLINICAL TESTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 112
TABLE 47 LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS,
BY COUNTRY, 2016–2023 (USD MILLION) 114
TABLE 48 LATERAL FLOW ASSAYS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING, BY COUNTRY, 2016–2023 (USD MILLION) 115
TABLE 49 LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2016–2023 (USD MILLION) 117
TABLE 50 LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION) 119
TABLE 51 LATERAL FLOW SANDWICH ASSAYS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 120
TABLE 52 LATERAL FLOW COMPETITIVE ASSAYS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 121
TABLE 53 LATERAL FLOW MULTIPLEX DETECTION ASSAYS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 122
TABLE 54 LATERAL FLOW ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION) 124
TABLE 55 LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY,
2016–2023 (USD MILLION) 125
TABLE 56 LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES,
BY COUNTRY, 2016–2023 (USD MILLION) 126
TABLE 57 LATERAL FLOW ASSAYS MARKET FOR HOME CARE, BY COUNTRY,
2016–2023 (USD MILLION) 128
TABLE 58 LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION) 129
TABLE 59 LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY,
2016–2023 (USD MILLION) 130
TABLE 60 LATERAL FLOW ASSAYS MARKET, BY REGION, 2016–2023 (USD MILLION) 133
TABLE 61 NORTH AMERICA: MACROECONOMIC INDICATORS 134
TABLE 62 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 136
TABLE 63 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 136
TABLE 64 NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 136
TABLE 65 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 137
TABLE 66 NORTH AMERICA: CLINICAL TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 137
TABLE 67 NORTH AMERICA: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 138
TABLE 68 NORTH AMERICA: SEXUALLY TRANSMITTED INFECTION TESTING MARKET,
BY TYPE, 2016–2023 (USD MILLION) 138
TABLE 69 NORTH AMERICA: CARDIAC MARKER TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 139
TABLE 70 NORTH AMERICA: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 139
TABLE 71 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION) 139
TABLE 72 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION) 140
TABLE 73 US: MACROECONOMIC INDICATORS 141
TABLE 74 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 141
TABLE 75 US: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 141
TABLE 76 US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 142
TABLE 77 US: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 142
TABLE 78 US: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 143
TABLE 79 US: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 143
TABLE 80 US: CARDIAC MARKER TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 144
TABLE 81 US: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 144
TABLE 82 US: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION) 144
TABLE 83 US: LATERAL FLOW ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION) 145
TABLE 84 CANADA: MACROECONOMIC INDICATORS 146
TABLE 85 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 146
TABLE 86 CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 146
TABLE 87 CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 147
TABLE 88 CANADA: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 147
TABLE 89 CANADA: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 148
TABLE 90 CANADA: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 148
TABLE 91 CANADA: CARDIAC MARKER TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 149
TABLE 92 CANADA: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 149
TABLE 93 CANADA: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION) 149
TABLE 94 CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION) 150
TABLE 95 EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 152
TABLE 96 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 152
TABLE 97 EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 152
TABLE 98 EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 153
TABLE 99 EUROPE: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 153
TABLE 100 EUROPE: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 154
TABLE 101 EUROPE: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 154
TABLE 102 EUROPE: CARDIAC MARKER TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 155
TABLE 103 EUROPE: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 155
TABLE 104 EUROPE: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION) 155
TABLE 105 EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION) 156
TABLE 106 GERMANY: MACROECONOMIC INDICATORS 157
TABLE 107 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 157
TABLE 108 GERMANY: LATERAL FLOW READERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 157
TABLE 109 GERMANY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 158
TABLE 110 GERMANY: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 158
TABLE 111 GERMANY: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 159
TABLE 112 GERMANY: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 159
TABLE 113 GERMANY: CARDIAC MARKER TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 160
TABLE 114 GERMANY: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 160
TABLE 115 GERMANY: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION) 160
TABLE 116 GERMANY: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION) 161
TABLE 117 FRANCE: MACROECONOMIC INDICATORS 162
TABLE 118 FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 162
TABLE 119 FRANCE: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 162
TABLE 120 FRANCE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 163
TABLE 121 FRANCE: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 163
TABLE 122 FRANCE: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 164
TABLE 123 FRANCE: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 164
TABLE 124 FRANCE: CARDIAC MARKER TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 165
TABLE 125 FRANCE: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 165
TABLE 126 FRANCE: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION) 165
TABLE 127 FRANCE: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION) 166
TABLE 128 UK: MACROECONOMIC INDICATORS 167
TABLE 129 UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 167
TABLE 130 UK: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 167
TABLE 131 UK: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 168
TABLE 132 UK: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 168
TABLE 133 UK: INFECTIOUS DISEASE TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 169
TABLE 134 UK: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 169
TABLE 135 UK: CARDIAC MARKER TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 170
TABLE 136 UK: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 170
TABLE 137 UK: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE, 2016–2023 (USD MILLION) 170
TABLE 138 UK: LATERAL FLOW ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION) 171
TABLE 139 ITALY: MACROECONOMIC INDICATORS 172
TABLE 140 ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 172
TABLE 141 ITALY: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 172
TABLE 142 ITALY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 173
TABLE 143 ITALY: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 173
TABLE 144 ITALY: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 174
TABLE 145 ITALY: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 174
TABLE 146 ITALY: CARDIAC MARKER TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 175
TABLE 147 ITALY: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 175
TABLE 148 ITALY: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION) 175
TABLE 149 ITALY: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION) 176
TABLE 150 SPAIN: MACROECONOMIC INDICATORS 177
TABLE 151 SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 177
TABLE 152 SPAIN: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 177
TABLE 153 SPAIN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 178
TABLE 154 SPAIN: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 178
TABLE 155 SPAIN: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 179
TABLE 156 SPAIN: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 179
TABLE 157 SPAIN: CARDIAC MARKER TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 180
TABLE 158 SPAIN: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 180
TABLE 159 SPAIN: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION) 180
TABLE 160 SPAIN: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION) 181
TABLE 161 ROE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 181
TABLE 162 ROE: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 182
TABLE 163 ROE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 182
TABLE 164 ROE: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 183
TABLE 165 ROE: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 183
TABLE 166 ROE: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 184
TABLE 167 ROE: CARDIAC MARKER TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 184
TABLE 168 ROE: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 185
TABLE 169 ROE: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION) 185
TABLE 170 ROE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION) 185
TABLE 171 APAC: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 188
TABLE 172 APAC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 188
TABLE 173 APAC: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 188
TABLE 174 APAC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 189
TABLE 175 APAC: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 189
TABLE 176 APAC: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 190
TABLE 177 APAC: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 190
TABLE 178 APAC: CARDIAC MARKER TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 191
TABLE 179 APAC: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 191
TABLE 180 APAC: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION) 191
TABLE 181 APAC: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION) 192
TABLE 182 CHINA: MACROECONOMIC INDICATORS 193
TABLE 183 CHINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 193
TABLE 184 CHINA: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 193
TABLE 185 CHINA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 194
TABLE 186 CHINA: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 194
TABLE 187 CHINA: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 195
TABLE 188 CHINA: SEXUALLY TRANSMITTED INFECTION TESTING MARKET,
BY TYPE, 2016–2023 (USD MILLION) 195
TABLE 189 CHINA: CARDIAC MARKER TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 196
TABLE 190 CHINA: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 196
TABLE 191 CHINA: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION) 196
TABLE 192 CHINA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION) 197
TABLE 193 JAPAN: MACROECONOMIC INDICATORS 198
TABLE 194 JAPAN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 198
TABLE 195 JAPAN: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 198
TABLE 196 JAPAN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 199
TABLE 197 JAPAN: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 199
TABLE 198 JAPAN: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 200
TABLE 199 JAPAN: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 200
TABLE 200 JAPAN: CARDIAC MARKER TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 201
TABLE 201 JAPAN: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 201
TABLE 202 JAPAN: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION) 201
TABLE 203 JAPAN: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION) 202
TABLE 204 INDIA: MACROECONOMIC INDICATORS 203
TABLE 205 INDIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 203
TABLE 206 INDIA: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 203
TABLE 207 INDIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 204
TABLE 208 INDIA: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 204
TABLE 209 INDIA: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 205
TABLE 210 INDIA: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 205
TABLE 211 INDIA: CARDIAC MARKER TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 206
TABLE 212 INDIA: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 206
TABLE 213 INDIA: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION) 206
TABLE 214 INDIA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION) 207
TABLE 215 ROAPAC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 207
TABLE 216 ROAPAC: LATERAL FLOW READERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 208
TABLE 217 ROAPAC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 208
TABLE 218 ROAPAC: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 209
TABLE 219 ROAPAC: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 209
TABLE 220 ROAPAC: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 210
TABLE 221 ROAPAC: CARDIAC MARKER TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 210
TABLE 222 ROAPAC: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 211
TABLE 223 ROAPAC: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION) 211
TABLE 224 ROAPAC: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION) 211
TABLE 225 BRAZIL: MACROECONOMIC INDICATORS 212
TABLE 226 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 213
TABLE 227 LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 213
TABLE 228 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 213
TABLE 229 LATIN AMERICA: CLINICAL TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 214
TABLE 230 LATIN AMERICA: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 214
TABLE 231 LATIN AMERICA: SEXUALLY TRANSMITTED INFECTION TESTING MARKET,
BY TYPE, 2016–2023 (USD MILLION) 215
TABLE 232 LATIN AMERICA: CARDIAC MARKER TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 215
TABLE 233 LATIN AMERICA: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 216
TABLE 234 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION) 216
TABLE 235 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION) 216
TABLE 236 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 217
TABLE 237 MIDDLE EAST & AFRICA: LATERAL FLOW READERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 218
TABLE 238 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 218
TABLE 239 MIDDLE EAST & AFRICA: CLINICAL TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 219
TABLE 240 MIDDLE EAST & AFRICA: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 219
TABLE 241 MIDDLE EAST & AFRICA: SEXUALLY TRANSMITTED INFECTION TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 220
TABLE 242 MIDDLE EAST & AFRICA: CARDIAC MARKER TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 220
TABLE 243 MIDDLE EAST & AFRICA: PREGNANCY & FERTILITY TESTING MARKET,
BY TYPE, 2016–2023 (USD MILLION) 221
TABLE 244 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE,
2016–2023 (USD MILLION) 221
TABLE 245 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2016–2023 (USD MILLION) 222
TABLE 246 PRODUCT LAUNCHES (2018) 228
TABLE 247 ACQUISITIONS (2017-2018) 228
TABLE 248 COLLABORATIONS, AGREEMENT, AND PARTNERSHIPS (2017-2018) 229
TABLE 249 EXPANSIONS (2016-2017) 229


LIST OF FIGURES

FIGURE 1 LATERAL FLOW ASSAYS MARKET 27
FIGURE 2 RESEARCH DESIGN 30
FIGURE 3 PRIMARY SOURCES 33
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATIONS, AND REGION 36
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATIONS, AND REGION 36
FIGURE 6 DATA TRIANGULATION METHODOLOGY 39
FIGURE 7 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION) 41
FIGURE 8 LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE, 2018 VS. 2023 (USD MILLION) 42
FIGURE 9 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION) 42
FIGURE 10 LATERAL FLOW ASSAYS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION) 43
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAYS MARKET 44
FIGURE 12 RAPID GROWTH IN THE GERIATRIC POPULATION–KEY FACTOR
DRIVING MARKET GROWTH FOR LATERAL FLOW ASSAYS 45
FIGURE 13 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING
THE FORECAST PERIOD 46
FIGURE 14 CHINA TO GROW AT THE FASTEST RATE DURING FORECAST PERIOD 47
FIGURE 15 NORTH AMERICA WILL CONTINUE TO DOMINATE THE LATERAL FLOW ASSAYS MARKET THROUGH 2023 48
FIGURE 16 CLINICAL TESTING SEGMENT AND CHINA COMMANDED THE LARGEST SHARE OF THE ASIA PACIFIC LATERAL FLOW ASSAYS MARKET IN 2017 49
FIGURE 17 PREVALENCE OF INFECTIOUS DISEASES WORLDWIDE 51
FIGURE 18 GLOBAL GERIATRIC POPULATION, BY REGION, 2010 VS. 2015 VS. 2030 53
FIGURE 19 ELDERLY POPULATION, BY COUNTRY, 2010 VS. 2017 (MILLION) 53
FIGURE 20 LATERAL FLOW ASSAYS MARKET: VALUE CHAIN ANALYSIS (2017) 60
FIGURE 21 LATERAL FLOW ASSAYS MARKET: SUPPLY CHAIN ANALYSIS (2017) 61
FIGURE 22 MICROFLUIDICS MARKET TO REGISTER THE HIGHEST CAGR FROM 2018 TO 2023 65
FIGURE 23 IN VITRO DIAGNOSTICS: MARKET SNAPSHOT 66
FIGURE 24 POINT-OF-CARE DIAGNOSTICS: MARKET SNAPSHOT 67
FIGURE 25 MICROFLUIDICS MARKET: MARKET SNAPSHOT 68
FIGURE 26 CAPILLARY ELECTROPHORESIS SYSTEMS: MARKET SNAPSHOT 69
FIGURE 27 KITS & REAGENTS SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL LATERAL FLOW ASSAYS MARKET IN 2023 71
FIGURE 28 CLINICAL TESTING SEGMENT TO DOMINATE THE LATERAL FLOW ASSAYS MARKET, BY APPLICATION, DURING THE FORECAST PERIOD 78
FIGURE 29 PATIENTS BEING TREATED FOR HIV GLOBALLY, 2000–2015 87
FIGURE 30 SANDWICH ASSAYS TO DOMINATE THE LATERAL FLOW ASSAYS MARKET DURING THE FORECAST PERIOD 119
FIGURE 31 HOSPITALS & CLINICS TO DOMINATE THE LATERAL FLOW ASSAYS MARKET DURING THE FORECAST PERIOD 124
FIGURE 32 NORTH AMERICA TO DOMINATE THE MARKET DURING FORECAST PERIOD 132
FIGURE 33 CHINA TO GROW AT THE FASTEST RATE DURING THE FORECAST PERIOD 133
FIGURE 34 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT 135
FIGURE 35 EUROPE: LATERAL FLOW ASSAYS MARKET SNAPSHOT 151
FIGURE 36 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET SNAPSHOT 187
FIGURE 37 KEY DEVELOPMENTS IN THE LATERAL FLOW ASSAYS MARKET BETWEEN
2015 AND 2018 223
FIGURE 38 LATERAL FLOW ASSAY PRODUCT PORTFOLIO MATRIX 224
FIGURE 39 GEOGRAPHICAL REVENUE MIX: LATERAL FLOW ASSAYS MARKET (2017) 225
FIGURE 40 LATERAL FLOW ASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER (2017) 226
FIGURE 41 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAYS MARKET 2015 & 2017 230
FIGURE 42 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2017) 231
FIGURE 43 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2017) 236
FIGURE 44 DANAHER CORPORATION: COMPANY SNAPSHOT (2017) 240
FIGURE 45 SIEMENS AG: COMPANY SNAPSHOT (2017) 244
FIGURE 46 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2017) 248
FIGURE 47 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2017) 252
FIGURE 48 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2017) 255
FIGURE 49 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2017) 258
FIGURE 50 QIAGEN N.V.: COMPANY SNAPSHOT (2017) 263
FIGURE 51 PERKINELMER INC.: COMPANY SNAPSHOT (2017) 266
FIGURE 52 HOLOGIC, INC.: COMPANY SNAPSHOT (2017) 270
FIGURE 53 QUIDEL CORPORATION: COMPANY SNAPSHOT (2017) 273
FIGURE 54 MERCK KGAA: COMPANY SNAPSHOT (2017) 276
FIGURE 55 KNOWLEDGE STORE SNAPSHOT 285
FIGURE 56 MARKETSANDMARKETS KNOWLEDGE STORE: HEALTHCARE INDUSTRY SNAPSHOT 286


★調査レポート[ラテラルフローアッセイの世界市場予測(~2023年)] (コード:MD-4158)販売に関する免責事項を必ずご確認ください。
★調査レポート[ラテラルフローアッセイの世界市場予測(~2023年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆